Clinical Trials Logo
  1. Home
  2. Non-infectious Uveitis
  3. NCT00720928

Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's Disease

Non-Infectious Uveitis Clinical Trial

Official title:
A Multi-Center, Prospective Single Arm Study to Assess the Efficacy and Safety of RETISERT (Intravitreal Flucinolone Acetonide 0.59mg) in Patients With Refractory Ocular Behcet's Disease

Clinical Trial Summary

Objectives:

To describe the safety and efficacy of intravitreal flucinolone acetonide implants in the management of patients having refractory ocular Behcet's disease

Hypothesis:

A descriptive observational study

Study design:

A 1-year, multi-center (including four Korean medical centers) observational study

Clinical Trial Description

A multi-center, prospective single arm study to assess the efficacy and safety of retisert (intravitreal flucinolone acetonide 0.59 mg) in patients with refractory ocular Behcet's disease. This study will be conducted at 4 sites, located in Korea. The number of subject is expected approximately 15 patients. The medical records for the patients meeting following inclusion/exclusion criteria will be collected until 1 year after implantation. ;

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00720928
Study type Interventional
Source Asan Medical Center
Contact Young Hee Yoon, MD
Phone 822-3010-3675
Email yhyoon@amc.seoul.kr
Status Recruiting
Phase Phase 4
Start date July 2008
Completion date May 2010
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05928754 - Prospective CoHoRt Of Non-infectious Intermediate, pOsterior or panuveitiS N/A
Terminated NCT00646425 - The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis Phase 2
Terminated NCT00456482 - Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant Phase 2/Phase 3
Completed NCT04018599 - Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS Phase 1
Terminated NCT02951975 - Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Active, not recruiting NCT03634475 - A Safety Study of Intravitreal PP-001 in Patients With Chronic, Non-Infectious Uveitis Phase 1/Phase 2
Completed NCT04207983 - A 48 Week Study to Evaluate the Efficacy and Safety of Two (2) EYS606 Treatment Regimens in Subjects With Active Chronic Non-infectious Uveitis (CNIU) Phase 2
Completed NCT02748512 - Utilization and Safety of the Mk II Inserter and the Safety of the FAI Insert in Non-Infectious Uveitis Phase 3
Recruiting NCT02706704 - Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis Phase 2
Terminated NCT01032915 - Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis Phase 3
Not yet recruiting NCT04105452 - Study to Evaluate PL8177 in Subjects With Non Infectious Uveitis (NIU) Phase 2
Terminated NCT01090310 - Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis Phase 3
Completed NCT01694186 - Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert Phase 3
Completed NCT03308045 - Evaluation of EYS606 in Patients With Non-infectious Posterior, Intermediate or Panuveitis Phase 1/Phase 2
Completed NCT00468871 - Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy Phase 2/Phase 3